2007
DOI: 10.2174/138920307781369391
|View full text |Cite
|
Sign up to set email alerts
|

Free Resources to Assist Structure-Based Virtual Ligand Screening Experiments

Abstract: In today's research environment, a wealth of experimental/theoretical structural data is available and the number of therapeutically relevant macromolecular structures is growing rapidly. This, coupled with the huge number of small non-peptide potential drug candidates easily available (over 7 million compounds), highlight the need of using computer-aided techniques for the efficient identification and optimization of novel hit compounds. Virtual (or in silico) ligand screening based on the three-dimensional s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
53
0

Year Published

2008
2008
2021
2021

Publication Types

Select...
5
3
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 105 publications
(53 citation statements)
references
References 164 publications
(187 reference statements)
0
53
0
Order By: Relevance
“…Several ADME/Tox methods had been proposed at least a decade ago, and the application or comparison of these programs has been extensively studied (Ekins et al, 2000b(Ekins et al, , 2001aEkins, 2007;Villoutreix et al, 2007;Lagorce et al, 2008). The challenge is not only that sizable drug discovery data (training sets) are lacking for model building but also that there has been no mechanism to bring together isolated training sets, especially the very large proprietary datasets from different companies.…”
Section: Introductionmentioning
confidence: 99%
“…Several ADME/Tox methods had been proposed at least a decade ago, and the application or comparison of these programs has been extensively studied (Ekins et al, 2000b(Ekins et al, , 2001aEkins, 2007;Villoutreix et al, 2007;Lagorce et al, 2008). The challenge is not only that sizable drug discovery data (training sets) are lacking for model building but also that there has been no mechanism to bring together isolated training sets, especially the very large proprietary datasets from different companies.…”
Section: Introductionmentioning
confidence: 99%
“…2) [222]. Previous successful development of protein inhibitors using free virtual screening packages, mainly AutoDock and DOCK, have been reviewed by Bruno et al in their review [223]. Tanaji et al reviewed the development of 12 small molecules that have entered late clinical trials or final approved by FDA for therapeutic use as direct consequences of structure-based drug design [224].…”
Section: Targeting Protein-ligand Interactionmentioning
confidence: 99%
“…Ligand-based approaches include similarity searching, substructure, clustering, quantitative structure-activity relationships (QSAR), pharmacophore-, or three-dimensional shape matching techniques (Villoutreix et al, 2007). Several ligand-based methods, including similarity searching and QSAR, can roughly be divided into two-or three-dimensional approaches.…”
Section: Ligand-based Screeningmentioning
confidence: 99%